Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Clinical trial NCT00311441 · COMPLETED

Trial details

NCT number: NCT00311441
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Encephalitis, Tick-Borne

Start date: 2005-03-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.